By
AmyT on
January 8, 2010
I’m very excited to announce that we’re currently in the early stages of preparing for the 2010 DiabetesMine Design Challenge. Look, we’ve even updated the logo:
For those of you not familiar with it, this is an annual innovation competition to encourage creative new tools for improving life with diabetes. The contest is generously sponsored by the California HealthCare Foundation (CHCF); and supported by Medgadget.com, the Internet journal of emerging medical technologies, and the world-renowned…
Read more »
By
AmyT on
December 8, 2009
Larry Ishler is an electrical engineer living in Erie, PA, whose son was diagnosed with Type 1 diabetes in college about ten years ago. A few years later, the father had an idea for a non-invasive glucose monitor that would take readings through the skin on your ear (similar to the GlucoTrack from Integrity Applications out of Israel). For years now, he has researched, calculated, tested, and attempted to gain support for his highly accurate…
Read more »
By
AmyT on
November 12, 2009
The Diabetes Technology Society held its annual meeting last Thursday through Saturday, which always takes place just about a mile and a half from my house. But guess what? This was the very first year that I found myself on the inside of this exclusive event, participating in a panel (the very last panel of the 3-day event) on “technologies to drive patient adherence.”
The term “adherence” made me bristle, too, because it sounds like…
Read more »
By
AmyT on
October 26, 2009
We tend to assume that the big companies making glucose monitoring products do nothing but sit around thinking about how they can sell more product. You can’t blame us; it sure looks that way from the outside. But late last week I was privileged to get an inside view of some of the real innovation going on behind closed doors.
I was invited to visit Roche’s New Concept Incubator, a small “think tank” of about…
Read more »
By
AmyT on
October 12, 2009
MannKind Corp., the most aggressive company pushing ahead on bringing inhalable insulin to market post the Exubera debacle, took a hit last week when it was forced to announce that a critical marketing partnership didn’t pan out. Investors are now fighting over the company’s future.
As a PWD who watched the whole sordid Exubera story play out with a sad smirk on my face (we all knew the product was too clunky and hard to…
Read more »
